[96a5a0]: / output / allTrials / identified / NCT05236582_identified.json

Download this file

871 lines (871 with data), 37.7 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
{
"info": {
"nct_id": "NCT05236582",
"official_title": "Herombopag for Chemotherapy-induced Thrombocytopenia: a Prospective Multi-center One-arm Study in Solid Tumors",
"inclusion_criteria": "* Aged ≥18 years old, male or female;\n* Conform to the diagnostic criteria of chemotherapy-induced thrombocytopenia (CIT); Ineffective after repeated treatment with rhTPO or IL-11;\n* Stop radiotherapy or chemotherapy for more than 1 month;\n* Platelet counts <30 ×10^9/L, and bleeding tendency;\n* Estimated survival period ≥ 6 months;\n* People who are willing to sign the informed consent voluntarily and follow the research program.\n* Liver and kidney function<1.5×upper limit of normal, qualified for physical examination;\n* Subject is practicing an acceptable method of contraception. Women of childbearing potential must have a negative serum pregnancy test in the whole study;\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Those with uncontrollable primary diseases of important organs, such as extensive metastasis of malignant tumors, liver failure, heart failure, kidney failure and other diseases;\n* Patients with poor compliance;\n* Positive serology for HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), and/or hepatitis D virus (HDV), Syphilis; Positive for Epstein-Barr Virus DNA, Cytomegalovirus DNA;\n* Accompanied by extensive and severe bleeding, such as hemoptysis, upper gastrointestinal bleeding, intracranial hemorrhage, etc.\n* There is currently a heart disease requiring treatment or a poorly controlled hypertension judged by the investigator;\n* Patients with thrombotic diseases such as pulmonary embolism, thrombosis, and atherosclerosis;\n* Those who have received allogeneic stem cell transplantation or organ transplantation in the past;\n* Patients with mental disorders who cannot normally obtain informed consent and undergo trials and follow-up;\n* Patients whose toxic symptoms caused by treatment before participating in the trial have not disappeared;\n* Other serious diseases that may restrict participants from participating in this trial (such as diabetes; severe heart failure; myocardial obstruction or unstable arrhythmia or unstable angina in the past 6 months; gastric ulcers; mobility Autoimmune diseases, etc.);\n* Patients with sepsis or patients with other irregular bleeding;\n* Patients taking antiplatelet drugs at the same time;\n* Pregnant women, suspected pregnancy (a positive pregnancy test for human chorionic gonadotropin in urine at screening) and breastfeeding patients;\n* Pre-existing cardiac disease, including congestive heart failure of New York Heart Association [NYHA] Grade III/IV, arrhythmia requiring treatment or myocardial infarction within the last 6 months. No arrhythmia known to increase the risk of thrombotic events (e.g. atrial fibrillation), or patients with a QT >450msec or QTc > 480 for patients with a Bundle Branch Block;\n* Researchers believe that patients should not participate in the test of any other condition.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Aged ≥18 years old, male or female;",
"criterions": [
{
"exact_snippets": "Aged ≥18 years old",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
},
{
"exact_snippets": "male or female",
"criterion": "gender",
"requirements": [
{
"requirement_type": "allowed genders",
"expected_value": [
"male",
"female"
]
}
]
}
]
},
{
"line": "* Conform to the diagnostic criteria of chemotherapy-induced thrombocytopenia (CIT); Ineffective after repeated treatment with rhTPO or IL-11;",
"criterions": [
{
"exact_snippets": "Conform to the diagnostic criteria of chemotherapy-induced thrombocytopenia (CIT)",
"criterion": "chemotherapy-induced thrombocytopenia (CIT)",
"requirements": [
{
"requirement_type": "diagnostic criteria",
"expected_value": "conform"
}
]
},
{
"exact_snippets": "Ineffective after repeated treatment with rhTPO or IL-11",
"criterion": "treatment with rhTPO or IL-11",
"requirements": [
{
"requirement_type": "effectiveness",
"expected_value": "ineffective"
}
]
}
]
},
{
"line": "* Stop radiotherapy or chemotherapy for more than 1 month;",
"criterions": [
{
"exact_snippets": "Stop radiotherapy ... for more than 1 month",
"criterion": "radiotherapy",
"requirements": [
{
"requirement_type": "cessation duration",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "month"
}
}
]
},
{
"exact_snippets": "Stop ... chemotherapy for more than 1 month",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "cessation duration",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "month"
}
}
]
}
]
},
{
"line": "* Platelet counts <30 ×10^9/L, and bleeding tendency;",
"criterions": [
{
"exact_snippets": "Platelet counts <30 ×10^9/L",
"criterion": "platelet counts",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 30,
"unit": "×10^9/L"
}
}
]
},
{
"exact_snippets": "bleeding tendency",
"criterion": "bleeding tendency",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Estimated survival period ≥ 6 months;",
"criterions": [
{
"exact_snippets": "Estimated survival period ≥ 6 months",
"criterion": "survival period",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* People who are willing to sign the informed consent voluntarily and follow the research program.",
"criterions": [
{
"exact_snippets": "willing to sign the informed consent voluntarily",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
},
{
"exact_snippets": "follow the research program",
"criterion": "research program adherence",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
}
]
},
{
"line": "* Liver and kidney function<1.5×upper limit of normal, qualified for physical examination;",
"criterions": [
{
"exact_snippets": "Liver ... <1.5×upper limit of normal",
"criterion": "liver function",
"requirements": [
{
"requirement_type": "function level",
"expected_value": {
"operator": "<",
"value": 1.5,
"unit": "× upper limit of normal"
}
}
]
},
{
"exact_snippets": "kidney function<1.5×upper limit of normal",
"criterion": "kidney function",
"requirements": [
{
"requirement_type": "function level",
"expected_value": {
"operator": "<",
"value": 1.5,
"unit": "× upper limit of normal"
}
}
]
},
{
"exact_snippets": "qualified for physical examination",
"criterion": "physical examination",
"requirements": [
{
"requirement_type": "qualification",
"expected_value": true
}
]
}
]
},
{
"line": "* Subject is practicing an acceptable method of contraception. Women of childbearing potential must have a negative serum pregnancy test in the whole study;",
"criterions": [
{
"exact_snippets": "Subject is practicing an acceptable method of contraception",
"criterion": "contraception method",
"requirements": [
{
"requirement_type": "acceptability",
"expected_value": true
}
]
},
{
"exact_snippets": "Women of childbearing potential must have a negative serum pregnancy test",
"criterion": "serum pregnancy test",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Those with uncontrollable primary diseases of important organs, such as extensive metastasis of malignant tumors, liver failure, heart failure, kidney failure and other diseases;",
"criterions": [
{
"exact_snippets": "uncontrollable primary diseases of important organs, such as extensive metastasis of malignant tumors",
"criterion": "extensive metastasis of malignant tumors",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrollable primary diseases of important organs, such as ... liver failure",
"criterion": "liver failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrollable primary diseases of important organs, such as ... heart failure",
"criterion": "heart failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrollable primary diseases of important organs, such as ... kidney failure",
"criterion": "kidney failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients with poor compliance;",
"criterions": [
{
"exact_snippets": "Patients with poor compliance",
"criterion": "compliance",
"requirements": [
{
"requirement_type": "quality",
"expected_value": "poor"
}
]
}
]
},
{
"line": "* Positive serology for HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), and/or hepatitis D virus (HDV), Syphilis; Positive for Epstein-Barr Virus DNA, Cytomegalovirus DNA;",
"criterions": [
{
"exact_snippets": "Positive serology for HIV",
"criterion": "HIV serology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Positive serology for ... hepatitis B virus (HBV)",
"criterion": "hepatitis B virus (HBV) serology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Positive serology for ... hepatitis C virus (HCV)",
"criterion": "hepatitis C virus (HCV) serology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Positive serology for ... hepatitis D virus (HDV)",
"criterion": "hepatitis D virus (HDV) serology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Positive serology for ... Syphilis",
"criterion": "Syphilis serology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Positive for Epstein-Barr Virus DNA",
"criterion": "Epstein-Barr Virus DNA",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Positive for ... Cytomegalovirus DNA",
"criterion": "Cytomegalovirus DNA",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Accompanied by extensive and severe bleeding, such as hemoptysis, upper gastrointestinal bleeding, intracranial hemorrhage, etc.",
"criterions": [
{
"exact_snippets": "extensive and severe bleeding",
"criterion": "bleeding",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "extensive and severe"
}
]
},
{
"exact_snippets": "hemoptysis",
"criterion": "hemoptysis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "upper gastrointestinal bleeding",
"criterion": "upper gastrointestinal bleeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "intracranial hemorrhage",
"criterion": "intracranial hemorrhage",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* There is currently a heart disease requiring treatment or a poorly controlled hypertension judged by the investigator;",
"criterions": [
{
"exact_snippets": "heart disease requiring treatment",
"criterion": "heart disease",
"requirements": [
{
"requirement_type": "treatment requirement",
"expected_value": true
}
]
},
{
"exact_snippets": "poorly controlled hypertension",
"criterion": "hypertension",
"requirements": [
{
"requirement_type": "control",
"expected_value": "poorly controlled"
}
]
}
]
},
{
"line": "* Patients with thrombotic diseases such as pulmonary embolism, thrombosis, and atherosclerosis;",
"criterions": [
{
"exact_snippets": "thrombotic diseases such as pulmonary embolism, thrombosis, and atherosclerosis",
"criterion": "thrombotic diseases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "pulmonary embolism",
"criterion": "pulmonary embolism",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "thrombosis",
"criterion": "thrombosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "atherosclerosis",
"criterion": "atherosclerosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Those who have received allogeneic stem cell transplantation or organ transplantation in the past;",
"criterions": [
{
"exact_snippets": "received allogeneic stem cell transplantation",
"criterion": "allogeneic stem cell transplantation",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "received ... organ transplantation",
"criterion": "organ transplantation",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients with mental disorders who cannot normally obtain informed consent and undergo trials and follow-up;",
"criterions": [
{
"exact_snippets": "mental disorders",
"criterion": "mental disorders",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "cannot normally obtain informed consent",
"criterion": "ability to obtain informed consent",
"requirements": [
{
"requirement_type": "ability",
"expected_value": false
}
]
},
{
"exact_snippets": "undergo trials and follow-up",
"criterion": "ability to undergo trials and follow-up",
"requirements": [
{
"requirement_type": "ability",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients whose toxic symptoms caused by treatment before participating in the trial have not disappeared;",
"criterions": [
{
"exact_snippets": "toxic symptoms caused by treatment before participating in the trial have not disappeared",
"criterion": "toxic symptoms from prior treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Other serious diseases that may restrict participants from participating in this trial (such as diabetes; severe heart failure; myocardial obstruction or unstable arrhythmia or unstable angina in the past 6 months; gastric ulcers; mobility Autoimmune diseases, etc.);",
"criterions": [
{
"exact_snippets": "diabetes",
"criterion": "diabetes",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "severe heart failure",
"criterion": "severe heart failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "myocardial obstruction",
"criterion": "myocardial obstruction",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "unstable arrhythmia",
"criterion": "unstable arrhythmia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "unstable angina in the past 6 months",
"criterion": "unstable angina",
"requirements": [
{
"requirement_type": "recency",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
},
{
"exact_snippets": "gastric ulcers",
"criterion": "gastric ulcers",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "mobility Autoimmune diseases",
"criterion": "mobility autoimmune diseases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients with sepsis or patients with other irregular bleeding;",
"criterions": [
{
"exact_snippets": "Patients with sepsis",
"criterion": "sepsis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "patients with other irregular bleeding",
"criterion": "irregular bleeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients taking antiplatelet drugs at the same time;",
"criterions": [
{
"exact_snippets": "Patients taking antiplatelet drugs",
"criterion": "antiplatelet drug use",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Pregnant women, suspected pregnancy (a positive pregnancy test for human chorionic gonadotropin in urine at screening) and breastfeeding patients;",
"criterions": [
{
"exact_snippets": "Pregnant women",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "status",
"expected_value": "pregnant"
}
]
},
{
"exact_snippets": "suspected pregnancy (a positive pregnancy test for human chorionic gonadotropin in urine at screening)",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "status",
"expected_value": "suspected"
},
{
"requirement_type": "test result",
"expected_value": "positive"
}
]
},
{
"exact_snippets": "breastfeeding patients",
"criterion": "breastfeeding",
"requirements": [
{
"requirement_type": "status",
"expected_value": "breastfeeding"
}
]
}
]
},
{
"line": "* Pre-existing cardiac disease, including congestive heart failure of New York Heart Association [NYHA] Grade III/IV, arrhythmia requiring treatment or myocardial infarction within the last 6 months. No arrhythmia known to increase the risk of thrombotic events (e.g. atrial fibrillation), or patients with a QT >450msec or QTc > 480 for patients with a Bundle Branch Block;",
"criterions": [
{
"exact_snippets": "Pre-existing cardiac disease",
"criterion": "pre-existing cardiac disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "congestive heart failure of New York Heart Association [NYHA] Grade III/IV",
"criterion": "congestive heart failure",
"requirements": [
{
"requirement_type": "NYHA grade",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "N/A"
}
}
]
},
{
"exact_snippets": "arrhythmia requiring treatment",
"criterion": "arrhythmia",
"requirements": [
{
"requirement_type": "treatment requirement",
"expected_value": true
}
]
},
{
"exact_snippets": "myocardial infarction within the last 6 months",
"criterion": "myocardial infarction",
"requirements": [
{
"requirement_type": "time since event",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
},
{
"exact_snippets": "No arrhythmia known to increase the risk of thrombotic events (e.g. atrial fibrillation)",
"criterion": "arrhythmia increasing thrombotic risk",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "QT >450msec",
"criterion": "QT interval",
"requirements": [
{
"requirement_type": "length",
"expected_value": {
"operator": ">",
"value": 450,
"unit": "msec"
}
}
]
},
{
"exact_snippets": "QTc > 480 for patients with a Bundle Branch Block",
"criterion": "QTc interval with Bundle Branch Block",
"requirements": [
{
"requirement_type": "length",
"expected_value": {
"operator": ">",
"value": 480,
"unit": "msec"
}
}
]
}
]
},
{
"line": "* Researchers believe that patients should not participate in the test of any other condition.",
"criterions": [
{
"exact_snippets": "patients should not participate in the test of any other condition",
"criterion": "participation in other condition tests",
"requirements": [
{
"requirement_type": "participation",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}